[Inactivation of hepatitis non-A, non-B virus in intravenous immunoglobulins by beta-propiolactone].
Dichtelmüller
H
H
Biotest Pharma GmbH, Forschungsabteilung, Frankfurt, BRD.
Stephan
W
W
Prince
A M
AM
Brotman
B
B
D000818:Animals; D006526:Hepatitis C / Q000517:prevention & control* / Q000635:transmission; D006518:Hepatitis Viruses / Q000187:drug effects*; D006525:Hepatitis, Viral, Human / Q000517:prevention & control*; D007116:Immunization, Passive; D007783:Lactones / Q000494:pharmacology*; D002679:Pan troglodytes; D011420:Propiolactone / Q000494:pharmacology*; D013242:Sterilization; D014779:Virus Replication / Q000187:drug effects*
D007783:Lactones; D011420:Propiolactone
Inaktivierung von Hepatitis-NANB-Virus in i.v. Immunglobulinen durch beta-Propiolacton.